Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors
- PMID: 19618
Item in Clipboard
Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors
J Pharmacol Exp Ther.
1977 Sep.
No abstract available
Similar articles
-
Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.Commun Psychopharmacol. 1978;2(3):185-90. Commun Psychopharmacol. 1978. PMID: 29742 No abstract available.
-
The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.Biol Psychiatry. 1979 Jun;14(3):541-4. Biol Psychiatry. 1979. PMID: 573144 No abstract available.
-
Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.Res Commun Chem Pathol Pharmacol. 1977 Mar;16(3):411-23. Res Commun Chem Pathol Pharmacol. 1977. PMID: 847296
-
Pharmacology and biochemistry of haloperidol.Proc R Soc Med. 1976;69 suppl 1(Suppl 1):3-8. doi: 10.1177/00359157760690S102. Proc R Soc Med. 1976. PMID: 14331 Free PMC article. Review. No abstract available.
-
Animal models of tardive dyskinesia: their use in the search for new treatment methods.Mod Probl Pharmacopsychiatry. 1983;21:5-20. doi: 10.1159/000408479. Mod Probl Pharmacopsychiatry. 1983. PMID: 6140633 Review. No abstract available.
Cited by
-
Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.Psychopharmacology (Berl). 1984;84(4):512-9. doi: 10.1007/BF00431458. Psychopharmacology (Berl). 1984. PMID: 6441952
-
Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.Naunyn Schmiedebergs Arch Pharmacol. 1977 Dec;301(2):121-7. doi: 10.1007/BF00501426. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 202883
-
Reduction of dopaminergic supersensitivity by a single dose of amphetamine.Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):131-3. doi: 10.1007/BF00498568. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6106902
-
Dopaminergic supersensitivity after neuroleptics: time-course and specificity.Psychopharmacology (Berl). 1978 Dec 15;60(1):1-11. doi: 10.1007/BF00429171. Psychopharmacology (Berl). 1978. PMID: 32574 Review.
-
Brain locations controlling the behavioral effects of chronic amphetamine intoxication.Psychopharmacology (Berl). 1980;72(1):93-101. doi: 10.1007/BF00433812. Psychopharmacology (Berl). 1980. PMID: 6162168